Fennec Pharmaceuticals (FENC) Enterprise Value Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.93% |
| Sep 30, 2025 | 7.93% |
| Jun 30, 2025 | 13.55% |
| Mar 31, 2025 | -18.02% |
| Dec 31, 2024 | -14.30% |
| Sep 30, 2024 | -21.48% |
| Jun 30, 2024 | -25.83% |
| Mar 31, 2024 | -20.40% |
| Dec 31, 2023 | 10.25% |
| Sep 30, 2023 | 12.75% |
| Jun 30, 2023 | 10.22% |
| Mar 31, 2023 | 13.06% |
| Dec 31, 2022 | 3.40% |
| Sep 30, 2022 | -25.16% |
| Jun 30, 2022 | -7.83% |
| Mar 31, 2022 | -41.22% |
| Dec 31, 2021 | -39.98% |
| Sep 30, 2021 | -39.92% |
| Jun 30, 2021 | -39.97% |
| Mar 31, 2021 | -117.87% |
| Dec 31, 2020 | -100.26% |
| Sep 30, 2020 | -89.26% |
| Jun 30, 2020 | -83.65% |
| Mar 31, 2020 | -38.89% |
| Dec 31, 2019 | -42.70% |
| Sep 30, 2019 | -91.42% |
| Jun 30, 2019 | -68.16% |
| Mar 31, 2019 | -72.15% |
| Dec 31, 2018 | -68.79% |
| Sep 30, 2018 | -114.67% |
| Jun 30, 2018 | -91.06% |
| Mar 31, 2018 | -69.74% |
| Dec 31, 2017 | -65.11% |
| Sep 30, 2017 | -27.64% |
| Jun 30, 2017 | -23.33% |
| Mar 31, 2017 | 7.18% |
| Dec 31, 2016 | 5.81% |
| Sep 30, 2016 | 5.98% |
| Jun 30, 2016 | 5.69% |
| Mar 31, 2016 | 35.87% |
| Dec 31, 2015 | 30.82% |
| Sep 30, 2015 | 27.03% |
| Jun 30, 2015 | 23.66% |